290809-29-9

Basic information

• Product Name: Eupteleasaponin I
• Synonyms: Eupteleasaponin I
• CAS NO: 290809-29-9
• Molecular Formula: C52H82O21
• Molecular Weight: 1043.19
• Mol File: 290809-29-9.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.45±0.1 g/cm3(Predicted)
• PKA: 12.52±0.70(Predicted)
• CAS DataBase Reference: Eupteleasaponin I(CAS DataBase Reference)
• NIST Chemistry Reference: Eupteleasaponin I(290809-29-9)
• EPA Substance Registry System: Eupteleasaponin I(290809-29-9)

Safety Data

• Hazardous Substances Data: 290809-29-9(Hazardous Substances Data)

Usage

Description

Eupteleasaponin I is a naturally occurring triterpenoid saponin derived from the roots of Euptelea pleiosperma, a plant native to Asia. It is known for its potential medicinal properties, including anti-inflammatory, anti-tumor, and antioxidant activities. Eupteleasaponin I has demonstrated the ability to inhibit the growth and proliferation of cancer cells, as well as reduce inflammation and oxidative stress. Eupteleasaponin I is currently being investigated for its potential as a therapeutic agent for various diseases and conditions, garnering interest from researchers and scientists for its pharmacological properties and applications in medicine.

Uses

Used in Pharmaceutical Industry:
Eupteleasaponin I is used as a potential therapeutic agent for various diseases and conditions due to its anti-inflammatory, anti-tumor, and antioxidant properties. It is being investigated for its ability to inhibit the growth and proliferation of cancer cells, as well as reduce inflammation and oxidative stress.
Used in Cancer Treatment:
Eupteleasaponin I is used as an anti-cancer agent for its potential to inhibit the growth and proliferation of cancer cells. It may be employed in the development of novel cancer treatments, targeting various types of malignancies.
Used in Anti-Inflammatory Applications:
Eupteleasaponin I is used as an anti-inflammatory agent for its ability to reduce inflammation. It may be utilized in the development of treatments for inflammatory conditions, such as arthritis, asthma, and other inflammatory disorders.
Used in Antioxidant Formulations:
Eupteleasaponin I is used as an antioxidant agent for its potential to reduce oxidative stress. It may be incorporated into formulations for the prevention and treatment of oxidative stress-related conditions, such as neurodegenerative diseases and age-related disorders.
Used in Drug Delivery Systems:
Eupteleasaponin I may be used in the development of drug delivery systems to enhance its therapeutic efficacy and bioavailability. Researchers may explore the use of various carriers, such as organic and metallic nanoparticles, to improve the delivery of Eupteleasaponin I to target tissues and cells.